Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C L Davis

Showing results (181-190 of 415) with videos related to

Pageof 42
Sort By:
Virology|August 31, 2000
The p20 gene product of Citrus tristeza virus accumulates in the amorphous inclusion bodiesS Gowda, T Satyanarayana, C L Davis, et al.
Annals of Hematology|July 1, 1995
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patientsP K MacCallum, A Z Rohatiner, C L Davis, et al.
Journal of Medical Virology|January 1, 1983
Unrelatedness of factor VIII-derived non-A/non-B hepatitis and hepatitis B virusH A Fields, M Berninger, N Nath, et al.
Leukemia|October 1, 1993
Mitoxantrone and cytosine arabinoside as treatment for acute myelogenous leukemia (AML) at first recurrenceP K MacCallum, C L Davis, A Z Rohatiner, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 1, 1995
Hepatitis C--associated glomerular disease in liver transplant recipientsC L Davis, D R Gretch, J D Perkins, et al.
Hematological Oncology|March 1, 1992
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancyJ S Whelan, C L Davis, A Z Rohatiner, et al.
Transplantation|January 12, 1999
Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapyE J Novak, C M Blosch, J D Perkins, et al.
Kidney International|October 1, 1993
Expression of vascular cell adhesion molecule-1 in kidney allograft rejectionC E Alpers, K L Hudkins, C L Davis, et al.
Neuroendocrinology|January 1, 1993
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretionM A Kling, D R Rubinow, A R Doran, et al.
Journal of Diabetes and Its Complications|January 5, 2000
History of gestational diabetes, insulin resistance and coronary riskC L Davis, M Gutt, M M Llabre, et al.
Pageof 42

Showing results (181-190 of 415) with videos related to

Sort By:
Pageof 42
Virology|August 31, 2000
The p20 gene product of Citrus tristeza virus accumulates in the amorphous inclusion bodiesS Gowda, T Satyanarayana, C L Davis, et al.
Annals of Hematology|July 1, 1995
Mitoxantrone and cytosine arabinoside as treatment for acute myeloblastic leukemia in older patientsP K MacCallum, A Z Rohatiner, C L Davis, et al.
Journal of Medical Virology|January 1, 1983
Unrelatedness of factor VIII-derived non-A/non-B hepatitis and hepatitis B virusH A Fields, M Berninger, N Nath, et al.
Leukemia|October 1, 1993
Mitoxantrone and cytosine arabinoside as treatment for acute myelogenous leukemia (AML) at first recurrenceP K MacCallum, C L Davis, A Z Rohatiner, et al.
Liver Transplantation and Surgery : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|May 1, 1995
Hepatitis C--associated glomerular disease in liver transplant recipientsC L Davis, D R Gretch, J D Perkins, et al.
Hematological Oncology|March 1, 1992
Etoposide in combination with intermediate dose cytosine arabinoside (ID ARA C) given with the intention of further myeloablative therapy for the treatment of refractory or recurrent hematological malignancyJ S Whelan, C L Davis, A Z Rohatiner, et al.
Transplantation|January 12, 1999
Recombinant human tumor necrosis factor receptor Fc fusion protein therapy in kidney transplant recipients undergoing OKT3 induction therapyE J Novak, C M Blosch, J D Perkins, et al.
Kidney International|October 1, 1993
Expression of vascular cell adhesion molecule-1 in kidney allograft rejectionC E Alpers, K L Hudkins, C L Davis, et al.
Neuroendocrinology|January 1, 1993
Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretionM A Kling, D R Rubinow, A R Doran, et al.
Journal of Diabetes and Its Complications|January 5, 2000
History of gestational diabetes, insulin resistance and coronary riskC L Davis, M Gutt, M M Llabre, et al.
Pageof 42